Simavita Ltd. CDI | Balance Sheet

Fiscal year is July-June. All values CAD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
226.20
6,880.80
8,662.60
5,969.10
2,064.40
Total Accounts Receivable
-
1,404.50
1,547.40
1,854.50
1,332.30
Inventories
-
315.50
331.90
466.10
488.70
Other Current Assets
-
51.00
153.10
126.70
106.30
Total Current Assets
226.20
8,651.70
10,695.00
8,416.50
3,991.70
Net Property, Plant & Equipment
-
115.00
196.20
128.10
44.60
Intangible Assets
-
70.10
63.80
58.60
42.80
Total Assets
226.20
8,836.90
10,955.10
8,603.20
4,079.10
Accounts Payable
9.10
634.30
262.30
299.10
192.10
Income Tax Payable
-
10.60
9.10
15.10
12.60
Other Current Liabilities
-
621.00
838.30
836.00
710.40
Total Current Liabilities
9.10
1,265.90
1,109.70
1,150.30
915.10
Provision for Risks & Charges
-
-
66.60
58.20
79.70
Total Liabilities
9.10
1,265.90
1,176.20
1,208.50
994.80
Common Equity (Total)
217.10
7,571.00
9,778.90
7,394.70
3,084.30
Total Shareholders' Equity
217.10
7,571.00
9,778.90
7,394.70
3,084.30
Total Equity
217.10
7,571.00
9,778.90
7,394.70
3,084.30
Liabilities & Shareholders' Equity
226.20
8,836.90
10,955.10
8,603.20
4,079.10

About Simavita

View Profile
Address
54 Miller Street
North Sydney New South Wales (NSW) 2060
Australia
Employees -
Website http://www.simavita.com
Updated 09/14/2018
Simavita Ltd. engages in the provision of digital healthcare solutions. The company's activities include development and commercialization of wearable and disposable technology for the assessment and management of urinary incontinence. It operates through following geographic segments: Australia, North America and Europe.